Indication
Lymphocytopenia
2 clinical trials
4 products
Product
Interleukin-7Clinical trial
Recombinant Human InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic PAtients With COVID-19 Infection - "ILIAD 7 Trial" Brazil CohortStatus: Terminated, Estimated PCD: 2021-12-31
Product
PLACEBOProduct
CYT107Product
PlaceboClinical trial
A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Oncology CohortStatus: Terminated, Estimated PCD: 2022-06-30